Serum estradiol is associated with lean mass in elderly Swedish men.

OBJECTIVE Association studies in men have shown that androgens are inversely related to fat measures, while the relation between sex steroids and lean mass remains unclear. We, therefore, investigated the associations between serum sex steroid levels and body composition in elderly men with a main focus on lean mass measures. DESIGN AND METHODS A cross-sectional survey of a population-based cohort of 3014 elderly men, aged 69-80 years (Osteoporotic Fractures in Men study, Sweden). Serum levels of testosterone and estradiol (E(2)) were measured by mass spectrometry, sex hormone-binding globulin (SHBG) levels were measured by IRMA, and measures of body composition were obtained by dual-energy X-ray absorptiometry. RESULTS Total as well as free serum testosterone associated independently inversely (P<0.001), while total as well as free serum E(2) associated independently directly (P<0.001) with total body fat mass and trunk fat mass. Serum SHBG associated independently inversely with central fat distribution. Serum E(2) and free E(2) but not serum testosterone or free testosterone levels associated positively with lean mass (P<0.01). Elderly men within the lowest quartile of free E(2) had 0.5 kg less lean mass in the legs than subjects within the highest quartile, while the subjects in the different quartiles of free testosterone did not differ in lean mass. CONCLUSIONS Serum E(2), but not serum testosterone, is directly associated with lean mass in this large study of elderly Swedish men. In addition, serum SHBG is associated with central fat distribution and we confirmed that serum testosterone is inversely associated with fat mass.

[1]  David J Hunter,et al.  Sex hormone-binding globulin and risk of type 2 diabetes in women and men. , 2009, The New England journal of medicine.

[2]  S. Azen,et al.  Testosterone and growth hormone improve body composition and muscle performance in older men. , 2009, The Journal of clinical endocrinology and metabolism.

[3]  D. Lubahn,et al.  Estrogen receptor-alpha and -beta and aromatase knockout effects on lower limb muscle mass and contractile function in female mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[4]  T. Travison,et al.  Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  S. Boonen,et al.  Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor‐α , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  Hang Lee,et al.  Effects of aromatase inhibition in hypogonadal older men: a randomized, double‐blind, placebo‐controlled trial , 2009, Clinical endocrinology.

[7]  L. Woodhouse,et al.  Changes in Muscle Mass, Muscle Strength, and Power but Not Physical Function Are Related to Testosterone Dose in Healthy Older Men , 2008, Journal of the American Geriatrics Society.

[8]  T. Travison,et al.  Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  D. Mellström,et al.  Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  A. Silman,et al.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  A. Tchernof,et al.  Androgens and body fat distribution , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[13]  L. Lönn,et al.  Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  P. H. Petersen,et al.  Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. , 2007, The Journal of clinical endocrinology and metabolism.

[15]  T. Travison,et al.  The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. , 2007, The Journal of clinical endocrinology and metabolism.

[16]  Frederick C W Wu Commentary: Guideline for male testosterone therapy: a European perspective. , 2007, The Journal of clinical endocrinology and metabolism.

[17]  Claes Ohlsson,et al.  Serum Levels of Specific Glucuronidated Androgen Metabolites Predict BMD and Prostate Volume in Elderly Men , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  S. Cummings,et al.  Endogenous testosterone levels, physical performance, and fall risk in older men. , 2006, Archives of internal medicine.

[19]  S. Cummings,et al.  Comparison of methods to measure low serum estradiol levels in postmenopausal women. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  D. Grobbee,et al.  Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  P. Bélanger,et al.  Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  D. Kiel,et al.  Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. , 2006, The American journal of medicine.

[24]  O. Johnell,et al.  Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  J. Kaufman,et al.  The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.

[26]  Håkan Westerblad,et al.  Difference in skeletal muscle function in males vs. females: role of estrogen receptor-beta. , 2004, American journal of physiology. Endocrinology and metabolism.

[27]  J. Veldhuis,et al.  Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. , 2004, The Journal of clinical endocrinology and metabolism.

[28]  P. Delmas,et al.  Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. , 2004, The American journal of clinical nutrition.

[29]  P. Delmas,et al.  Role of sex steroids in the regulation of bone morphology in men. The MINOS study , 2004, Osteoporosis International.

[30]  Christina Wang,et al.  Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  Diederick E Grobbee,et al.  Endogenous sex hormones in men aged 40-80 years. , 2003, European journal of endocrinology.

[32]  W. Miller,et al.  Aromatase in skeletal muscle , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[33]  S. Boonen,et al.  Evidence From the Aged Orchidectomized Male Rat Model That 17β‐Estradiol Is a More Effective Bone‐Sparing and Anabolic Agent Than 5α‐Dihydrotestosterone , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  E. Metter,et al.  Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. , 2002, American journal of physiology. Endocrinology and metabolism.

[35]  Sundeep Khosla,et al.  Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.

[36]  R. Casaburi,et al.  Testosterone dose-response relationships in healthy young men. , 2001, American journal of physiology. Endocrinology and metabolism.

[37]  L. Melton,et al.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. , 2001, The Journal of clinical endocrinology and metabolism.

[38]  D. Grobbee,et al.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.

[39]  C. Bouchard,et al.  Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. , 2000, The Journal of clinical endocrinology and metabolism.

[40]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[41]  Preston Hormone containing growth promoting implants in farmed livestock. , 1999, Advanced drug delivery reviews.

[42]  R. Baumgartner,et al.  Predictors of skeletal muscle mass in elderly men and women , 1999, Mechanisms of Ageing and Development.

[43]  Rudolph L. Leibel,et al.  Medical progress: Obesity. , 1997 .

[44]  L. Sjöström,et al.  Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. , 1990, Metabolism: clinical and experimental.

[45]  D. Lubahn,et al.  Estrogen receptor-and-and aromatase knockout effects on lower limb muscle mass and contractile function in female mice , 2009 .

[46]  D. Blazer,et al.  Testosterone and aging : clinical research directions , 2004 .

[47]  P. Lundberg,et al.  Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. , 1986, Clinical chemistry.

[48]  C. Longcope,et al.  Aromatization of androgens by muscle and adipose tissue in vivo. , 1978, The Journal of clinical endocrinology and metabolism.